Long-term follow-up of childhood-onset hypopituitarism in patients with the PROP-1 gene mutation

Hormone Research

Volumn 60, Issue 4, 2003, Pages 168-173

  Pavel, Marianne E ^a   Hensen, Johannes ^b   Pfäffle, Roland ^c   Hahn, Eckhart G ^a   Dörr, Helmuth G ^d  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b NORDSTADT HOSPITAL   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Bone mineral density; Cortisol deficiency; Growth; PROP 1

Indexed keywords

CHORIONIC GONADOTROPIN; HUMAN GROWTH HORMONE; LIOTHYRONINE; METENOLONE ACETATE; TESTOSTERONE;

ADULT; ARTICLE; BONE AGE; BONE DENSITY; BONE MINERAL; CASE REPORT; DNA SEQUENCE; FOLLOW UP; GENE MUTATION; GROWTH HORMONE DEFICIENCY; HORMONE DEFICIENCY; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOPITUITARISM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; SHORT STATURE;

ADOLESCENT; AGE OF ONSET; BODY HEIGHT; BONE DENSITY; CHILD; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GROWTH HORMONE; HOMEODOMAIN PROTEINS; HORMONES; HUMANS; HYPOPITUITARISM; MALE; MUTATION; TESTOSTERONE; THYROXINE;

EID: 0141924093     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073228     Document Type: Article

References (15)

1. Cogan JD, Wu W, Phillips JA, Arnhold IJP, Agapito A, Fofanova OV, Osorio MGF, Bircan I, Moreno A, Mendonca BB: The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998;83:3346-3349.
2. Wu W, Cogan JD, Pfäffle RW, Dasen JS, Frisch H, O'Connell SM, Flynn SE, Brown MR, Mullis PE, Parks JS, Phillips JA, Rosenfeld MG: Mutations in Prop1 cause familial combined pituitary hormone deficiency. Nat Genet 1998;18:147-149.
3. Duquesnoy P, Roy A, Dastot F, Ghali I, Teinturier C, Netchine I, Cacheux V, Hafez M, Salah N, Chaussain JL, Goossens M, Bougneres P, Amselem S: Human Prop-1: Cloning, mapping, genomic structure. Mutations in familial combined pituitary hormone deficiency. FEBS Lett 1998;437:216-220.
4. Fovanova O, Takamura N, Kinoshita E, Parks JS, Brown MR, Peterkova VA, Evgrafov OV, Goncharov NP, Bulatov AA, Dedov II, Yamashita S: Compound heterozygous deletion of the PROP-1 gene in children with combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998;83:2601-2604.
5. Pfäffle RW, Blankenstein O, Wuller S, Kentrup H: Combined pituitary hormone deficiency: Role of Pit-1 and Prop-1. Acta Paediatr Suppl 1999;88:33-41.
6. Flück C, Deladoey J, Rutishauser K, Eblé A, Marti U, Wu W, Mullis PE: Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg → Cys at codon 120 (R120C). J Clin Endocrinol Metab 1998;83:3727-3734.
7. Mendonca BB, Osorio MGF, Latronico AC, Estefan V, Lo LSS, Arnhold IJP: Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301, G302 in the PROP1 gene. J Clin Endocrinol Metab 1999;84:942-945.
8. Asteria C, Oliveira JHA, Abucham J, Beck-Peccoz P: Central hypocortisolism as part of combined pituitary hormone deficiency due to mutations of PROP-1 gene. Eur J Endocrinol 2000;143:347-352.
9. Agarwal G, Bhatia V, Cook S, Thomas PQ: Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion. J Clin Endocrinol Metab 2000;85:4556-4561.
10. Pernasetti FM, Toledo SPA, Vasilyev VV, Hayashida CY, Cogan JD, Ferrari C, Lourenco DM, Mellon PL: Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302 delGA) in the prophet of Pit-1 gene. J Clin Endocrinol Metab 2000;85:390-397.
11. Osorio MG, Kopp P, Marui S, Latronico AC, Mendonca BB, Arnhold IJ: Combined pituitary hormone deficiency caused by a novel mutation of a highly conserved residue (F88S) in the homeodomain of PROP-1. J Clin Endocrinol Metab 2000;85:2779-2785.
12. Rodriguez-Arnao J, Perry L, Besser GM, Ross RJ: Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy. Clin Endocrinol 1996;45:33-37.
13. Moore JS, Monson JP, Kaltsas G, Putignano P, Wood PJ, Sheppard MC, et al: Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: In vivo and in vitro studies. J Clin Endocrinol Metab 1999;84:4172-4177.
14. Tschöp M, Lahner H, Feldmeier H, Grasberger H, Morrison KM, Janssen OE, Attanasio AF, Strasburger CJ: Effects of growth hormone replacement therapy on levels of cortisol and cortisol-binding globulin in hypopituitary adults. Eur J Endocrinol 2000;143:769-773.
15. Parks JS, Tenore A, Bongiovanni AM, Kirkland RT: Familial hypopituitarism with large sella turcica. N Engl J Medicine 1978;298:698-702.